No Data
No Data
No Data
No Data
No Data
T2 Biosystems Receives Notice Of Allowance For U.S. Patent Titled 'METHODS AND SYSTEMS FOR AMPLIFICATION IN COMPLEX SAMPLES (INCLUDING DIAGNOSTIC AND THERAPEUTICS METHODS FOR PATHOGENS IN WHOLE BLOOD)'
T2 Biosystems Receives Notice Of Allowance For U.S. Patent Titled 'METHODS AND SYSTEMS FOR AMPLIFICATION IN COMPLEX SAMPLES (INCLUDING DIAGNOSTIC AND THERAPEUTICS METHODS FOR PATHOGENS IN WHOLE BLOOD)
BenzingaApr 26 01:55
T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024
LEXINGTON, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today t
T2 BiosystemsApr 24 12:00
Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Nucor Corporation (NYSE:NUE) fell sharply during Tuesday's session after the company reported worse-than-expected quarterly financial results.Nucor reported quarterly earnings of $3.46 per s
BenzingaApr 24 01:53
Bio-Path Holdings, Sunshine Biopharma, INVO Bioscience Among Healthcare Movers
Seeking AlphaApr 23 22:00
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersImmunityBio (NASDAQ:IBRX) shares moved upwards by 32.0% to $6.52 during Tuesday's pre-market session. The company's market cap stands at $4.4 billion. Nuwellis (NASDAQ:NUWE) shares increased by
BenzingaApr 23 20:06
Top Premarket Decliners
Abeona Therapeutics (ABEO) shares slumped 48% Tuesday premarket after the company said that it plans to resubmit its biologic license application for pz-cel after the US Food and Drug Administration h
MT NewswiresApr 23 19:39
No Data
No Data